A. Jones

发表

Immunoassay for the detection of E. coli proteins in recombinant DNA derived human growth hormone.

Andrew J. S. Jones, Anthony B. Chen, B. Reed, 1986, Journal of immunological methods.

Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics.

T. Raju, J. Briggs, S. M. Borge, 2000, Glycobiology.

The Stabilization and Encapsulation of Human Growth Hormone into Biodegradable Microspheres

J. Cleland, Jeffrey L. Cleland, OluFunmi L. Johnson, 1997, Pharmaceutical Research.

Analysis of polypeptides and proteins

Andrew J. S. Jones, A. Jones, 1993 .

Stable Formulations of Recombinant Human Growth Hormone and Interferon-γ for Microencapsulation in Biodegradable Mircospheres

J. Cleland, Andrew J. S. Jones, A. Jones, 1996, Pharmaceutical Research.

Selective clearance of glycoforms of a complex glycoprotein pharmaceutical caused by terminal N-acetylglucosamine is similar in humans and cynomolgus monkeys.

Johannes Kneer, Yvonne S. Lin, J. Kneer, 2007, Glycobiology.

Comparison Between Light Induced and Chemically Induced Oxidation of rhVEGF

J. Cleland, R. Keck, Jeffrey L. Cleland, 2001, Pharmaceutical Research.

Glycoengineering of therapeutic glycoproteins: in vitro galactosylation and sialylation of glycoproteins with terminal N-acetylglucosamine and galactose residues.

J. Briggs, A. Jones, S. Chamow, 2001, Biochemistry.

An analytical system for the characterization of highly heterogeneous mixtures of N-linked oligosaccharides.

J. Briggs, R. Keck, Stacey Ma, 2009, Analytical biochemistry.

Analytical Characterization of Monoclonal Antibodies: Linking Structure to Function

Reed J. Harris, R. Keck, J. Battersby, 2010 .

A Precise and Rapid Microtitre Plate Clot Lysis Assay: Methodology, Kinetic Modeling and Measurement of Catalytic Constants for Plasminogen Activation during Fibrinolysis

A. Jones, A. Meunier, A. Jones, 1990, Thrombosis and Haemostasis.

Characterization of a complex glycoprotein whose variable metabolic clearance in humans is dependent on terminal N-acetylglucosamine content.

Stacey Ma, C. Kotts, L. Lerner, 2008, Biologicals : journal of the International Association of Biological Standardization.

Comparison of the rates of deamidation, diketopiperazine formation, and oxidation in recombinant human vascular endothelial growth factor and model peptides

R. Borchardt, Andrew J. S. Jones, C. Goolcharran, 2000, AAPS PharmSci.

The determination of recombinant human tissue-type plasminogen activator activity by turbidimetry using a microcentrifugal analyzer.

R. H. Carlson, R L Garnick, A. Jones, 1988, Analytical biochemistry.

A month–long effect from a single injection of microencapsulated human growth hormone

A. Shahzamani, J. Cleland, Jeffrey L. Cleland, 1996, Nature Medicine.

Pseudomonas Aeruginosa Secretes and Correctly Processes Human Growth Hormone

P. Seeburg, H. Heyneker, G. Gray, 1984, Bio/Technology.

Analysis of acidic oligosaccharides and glycopeptides by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

A. Jones, D. Papac, A. Wong, 1996, Analytical chemistry.

Recombinant human growth hormone poly(lactic-co-glycolic acid) (PLGA) microspheres provide a long lasting effect

Brooks M. Boyd, Chung C. Hsu, V. Mukku, 1997 .

The Stability of Recombinant Human Growth Hormone in Poly(lactic-co-glycolic acid) (PLGA) Microspheres

Brooks M. Boyd, Chung C. Hsu, V. Mukku, 1997, Pharmaceutical Research.